pharma · Chronic Inflammatory Demyelinating Polyneuropathy · Multifocal Motor Neuropathy · DNTH
Dianthus Therapeutics, Inc
Dianthus Therapeutics, Inc. /DE/
Dianthus Therapeutics, Inc trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
New York City, USA HQ
111 Employees
Public company Type
DNTH · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York City, USA
- Employees
- 111
- Programs
- 6
- Drugs
- 12
- Patents
- 2
Dianthus Therapeutics, Inc clinical trials
Registry index of 6 ClinicalTrials.gov studies linked to Dianthus Therapeutics, Inc programs — each row shows trial ID, program name, phase, status, and indication.
Dianthus Therapeutics, Inc trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Dianthus Therapeutics, Inc.
Trial registry
-
CTIS ↗ -
CTIS ↗ - 2024-517529-26-00CTIS ↗
Placebo matching DNTH103, DNTH103
Chronic Inflammatory Demyelinating Polyneuropathy
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗